This network meta-analysis compared different blood purification strategies against conventional therapy for patients with severe acute pancreatitis. The study included 3,707 patients from various settings, though the specific locations were not reported in the source data.
Researchers found that combining hemoperfusion with continuous renal replacement therapy ranked as the most effective intervention for lowering APACHE II scores, a measure of illness severity. Other combinations of these therapies also showed strong results for reducing markers like C-reactive protein and interleukin-6. For patients with high triglyceride levels, hemoperfusion combined with continuous renal replacement therapy showed the greatest improvement.
However, the analysis did not find a trend toward lower mortality with blood purification compared to standard care. The study authors noted that loop inconsistency was detected and heterogeneity could not be effectively resolved. They state that further high-quality trials are required to confirm the optimal blood purification strategy. Readers should interpret these findings with caution until more data is available.